Veridex Breaking News Grail Q1 Revenues up 19 Percent Driven by Clinical Test Growth Biodesix Q1 Revenues up 21 Percent as Firm Slashes Full-Year Guidance on Sales Restructuring Grail, Athenahealth Ink Deal to Facilitate Liquid Biopsy Test Ordering Qiagen Acquires NGS Analysis Software Firm Genoox for up to $80M Teal Health Wand Gets FDA Approval for At-Home HPV Self-Collection Top Five Articles on 360Dx Last Week: Castle Biosciences Buys Previse; Accelerate Dx's Bankruptcy; More
